260 related articles for article (PubMed ID: 28501670)
1. Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease.
Ratay ML; Glowacki AJ; Balmert SC; Acharya AP; Polat J; Andrews LP; Fedorchak MV; Schuman JS; Vignali DAA; Little SR
J Control Release; 2017 Jul; 258():208-217. PubMed ID: 28501670
[TBL] [Abstract][Full Text] [Related]
2. TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.
Ratay ML; Balmert SC; Acharya AP; Greene AC; Meyyappan T; Little SR
Sci Rep; 2017 Dec; 7(1):17527. PubMed ID: 29235530
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease.
Ratay ML; Balmert SC; Bassin EJ; Little SR
Acta Biomater; 2018 Apr; 71():261-270. PubMed ID: 29526828
[TBL] [Abstract][Full Text] [Related]
4. Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes.
Glowacki AJ; Yoshizawa S; Jhunjhunwala S; Vieira AE; Garlet GP; Sfeir C; Little SR
Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18525-30. PubMed ID: 24167272
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression.
Chauhan SK; El Annan J; Ecoiffier T; Goyal S; Zhang Q; Saban DR; Dana R
J Immunol; 2009 Feb; 182(3):1247-52. PubMed ID: 19155469
[TBL] [Abstract][Full Text] [Related]
6. Restoration of Regulatory T-Cell Function in Dry Eye Disease by Antagonizing Substance P/Neurokinin-1 Receptor.
Taketani Y; Marmalidou A; Dohlman TH; Singh RB; Amouzegar A; Chauhan SK; Chen Y; Dana R
Am J Pathol; 2020 Sep; 190(9):1859-1866. PubMed ID: 32473919
[TBL] [Abstract][Full Text] [Related]
7. Proteoglycan 4 (PRG4) expression and function in dry eye associated inflammation.
Menon NG; Goyal R; Lema C; Woods PS; Tanguay AP; Morin AA; Das N; Jay GD; Krawetz RJ; Dufour A; Shapiro LH; Redfern RL; Ghosh M; Schmidt TA
Exp Eye Res; 2021 Jul; 208():108628. PubMed ID: 34048779
[TBL] [Abstract][Full Text] [Related]
8. Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease.
Reyes JL; Vannan DT; Eksteen B; Avelar IJ; Rodríguez T; González MI; Mendoza AV
Mediators Inflamm; 2018; 2018():2532314. PubMed ID: 30158831
[TBL] [Abstract][Full Text] [Related]
9. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
Periman LM; Perez VL; Saban DR; Lin MC; Neri P
J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
[TBL] [Abstract][Full Text] [Related]
10. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis.
Chen Y; Chauhan SK; Lee HS; Stevenson W; Schaumburg CS; Sadrai Z; Saban DR; Kodati S; Stern ME; Dana R
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2457-64. PubMed ID: 23482465
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage.
Xia Y; Zhang Y; Du Y; Wang Z; Cheng L; Du Z
J Nanobiotechnology; 2024 May; 22(1):233. PubMed ID: 38725011
[TBL] [Abstract][Full Text] [Related]
12. Pigment Epithelium-Derived Factor Enhances the Suppressive Phenotype of Regulatory T Cells in a Murine Model of Dry Eye Disease.
Singh RB; Blanco T; Mittal SK; Alemi H; Chauhan SK; Chen Y; Dana R
Am J Pathol; 2021 Apr; 191(4):720-729. PubMed ID: 33453179
[TBL] [Abstract][Full Text] [Related]
13. Single-cell landscape reveals the epithelial cell-centric pro-inflammatory immune microenvironment in dry eye development.
Liu Z; Xie H; Li L; Jiang D; Qian Y; Zhu X; Dai M; Li Y; Wei R; Luo Z; Xu W; Zheng Q; Shen J; Zhou M; Zeng W; Chen W
Mucosal Immunol; 2024 Jun; 17(3):491-507. PubMed ID: 38007004
[TBL] [Abstract][Full Text] [Related]
14. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.
Barabino S; Chen Y; Chauhan S; Dana R
Prog Retin Eye Res; 2012 May; 31(3):271-85. PubMed ID: 22426080
[TBL] [Abstract][Full Text] [Related]
15. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
[TBL] [Abstract][Full Text] [Related]
16. Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.
Farid M; Agrawal A; Fremgen D; Tao J; Chuyi H; Nesburn AB; BenMohamed L
Ocul Immunol Inflamm; 2016 Jun; 24(3):327-47. PubMed ID: 25535823
[TBL] [Abstract][Full Text] [Related]
17. Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo.
Jhunjhunwala S; Raimondi G; Glowacki AJ; Hall SJ; Maskarinec D; Thorne SH; Thomson AW; Little SR
Adv Mater; 2012 Sep; 24(35):4735-8. PubMed ID: 22821823
[No Abstract] [Full Text] [Related]
18. Intravital Multiphoton Microscopy of the Ocular Surface: Alterations in Conventional Dendritic Cell Morphology and Kinetics in Dry Eye Disease.
Jamali A; Seyed-Razavi Y; Chao C; Ortiz G; Kenyon B; Blanco T; Harris DL; Hamrah P
Front Immunol; 2020; 11():742. PubMed ID: 32457740
[TBL] [Abstract][Full Text] [Related]
19. IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis.
Araujo-Pires AC; Vieira AE; Francisconi CF; Biguetti CC; Glowacki A; Yoshizawa S; Campanelli AP; Trombone AP; Sfeir CS; Little SR; Garlet GP
J Bone Miner Res; 2015 Mar; 30(3):412-22. PubMed ID: 25264308
[TBL] [Abstract][Full Text] [Related]
20. Effect of Dry Eye Disease on the Kinetics of Lacrimal Gland Dendritic Cells as Visualized by Intravital Multi-Photon Microscopy.
Ortiz G; Chao C; Jamali A; Seyed-Razavi Y; Kenyon B; Harris DL; Zoukhri D; Hamrah P
Front Immunol; 2020; 11():1713. PubMed ID: 32903439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
